Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2014


we.CONECT presents the ener.CON Award 2014

20 Mar 2014 - 21 Mar 2014 - Berlin, Germany



Bookmark and Share


For the first time we.CONECT bestows the ener.CON Award for the best energy efficiency project. The Award Ceremony will be part of the ener.CON Europe 2014 conference, taking place on March 20 – 21, 2014 in Berlin. The Award will be given to outstanding achievements and performance in Strategy & Management, Technology or Innovation. Advisory Board | Jury The ener.con AWARD 2014 is judged by a selected panel of expert professionals from a diverse range of sectors and is composed of the members of the event’s advisory board. Members of the advisory board include: • Michael Becker, Director Pfizer Global Engineering, Pfizer Inc. / Germany • Malte Homann, Global Energy Excellence Manager, Bayer Material Science AG / Germany • Bart Adams, Principal Consultant Sustainable Use, Head of Section, DNV KEMA / Belgium Boost your Project If you strive to see your project honored and celebrated by a thriving community, then don’t hesitate to apply for the ener.con AWARD 2014! Earn the recognition and reputation your project deserves and promote your concept among peers! Apply now for the ener.con AWARD 2014: http://www.we-conect.com/cms/media/uploads/events/435/dokumente/1403_enerCONAWARD_2014_application_interaktiv.pdf Download the application form, fill all information about your company and your project in and send it back to peter.haack@we-conect.com or fax it to +49 (0) 30 52 10 70 3 – 30 until February 25, 2014. In winning the ener.con AWARD 2014, the selected project will not only receive a certificate and respective trophy, but also enable the donation of a 2.000,00 Euro cheque on the company’s behalf to a corresponding charity project, as organized by we.CONECT. If you want to receive more information about the conditions of the award, the award ceremony or the ener.CON Europe 2014 conference, you are welcome to visit our website (http://enercon2014.we-conect.com/en/preview/award) or contact us: Peter Haack Marketing Development Commander Phone: +49 (0)30 52 10 70 3 - 42| Fax: +49 (0)30 52 10 70 3 - 30 Email: peter.haack@we-conect.com www.we-conect.com

Further information
Scientific News
Shedding Light on HIV Vaccine Design
Broadly speaking - Mathematical modelling of host-pathogen coevolution sheds light on HIV vaccine design.
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Lab-on-a-Stick: Miniaturised Clinical Testing For Fast Detection Of Antibiotic Resistance
A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading.
Genetic Ancestry of Cultivated Strawberry Unravelled
UNH scientists constructed a linkage map of the seven chromosomes of the diploid Fragaria iinumae, which allows them to fill in a piece of the genetic puzzle about the eight sets of chromosomes of the cultivated strawberry.
Progress In Vaccination Against Vespid Venom
Researchers at the Helmholtz Zentrum München and the Technical University Munich have presented a method which facilitates a personalised procedure for wasp allergy sufferers.
New Drug Target for Inflammatory Disorders
Penn study finds enigmatic molecules maintain equilibrium between fighting infection and inflammatory havoc.
Breast Cancer Cells Found To Switch Molecular Characteristics
Spontaneous interconversion between HER2-positive and HER2-negative states could contribute to progression, treatment resistance in breast cancer.
Mechanisms of Calcium Blockers
Researchers describe how the fundamental mode of action of two distinct chemical classes of calcium channel blockers differs.
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy
Genetic test can help predict survival and guide treatment options.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!